Covid-19 nasal vaccine could be a game-changer, says AIIMS epidemiologist
NEW DELHI :
As Hyderabad-based drug maker Bharat Biotech has got regulatory approval to conduct Phase-3 clinical trials of its intranasal COVID-19 vaccine as a booster dose, senior epidemiologist in All India…